CTIM-21. NRG-BN010: A SAFETY RUN-IN AND PHASE II STUDY EVALUATING THE COMBINATION OF TOCILIZUMAB, ATEZOLIZUMAB, AND FRACTIONATED STEREOTACTIC RADIOTHERAPY IN RECURRENT GLIOBLASTOMA–TRIAL IN PROGRESS

Publication Date

2022

Content Type

Article

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS